Deerfield Management’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-2,304,900
| Closed | -$196M | – | 148 |
|
|
2020
Q3 | $196M | Sell |
2,304,900
-256,100
| -10% | -$13M | 4.77% | 3 |
|
|
2020
Q2 | $90.8M | Sell |
2,561,000
-1,546,464
| -38% | -$45.2M | 2.64% | 8 |
|
|
2020
Q1 | $55.4M | Buy |
4,107,464
+2,384,846
| +138% | +$40.1M | 1.76% | 14 |
|
|
2019
Q4 | $36.5M | Sell |
1,722,618
-1,491,382
| -46% | -$26.3M | 1.16% | 30 |
|
|
2019
Q3 | $42.6M | Sell |
3,214,000
-1,771,383
| -36% | -$26M | 1.74% | 14 |
|
|
2019
Q2 | $69.1M | Buy |
4,985,383
+1,190,600
| +31% | +$17.9M | 2.48% | 9 |
|
|
2019
Q1 | $72.9M | Buy |
3,794,783
+1,961,581
| +107% | +$31.6M | 2.8% | 9 |
|
|
2018
Q4 | $26.2M | Buy |
1,833,202
+243,202
| +15% | +$4.83M | 1.05% | 38 |
|
|
2018
Q3 | $33.1M | Buy |
1,590,000
+465,200
| +41% | +$11M | 1.19% | 33 |
|
|
2018
Q2 | $26.6M | Buy |
1,124,800
+194,352
| +21% | +$3.91M | 0.94% | 43 |
|
|
2018
Q1 | $13.6M | Sell |
930,448
-370,000
| -28% | -$6.05M | 0.47% | 71 |
|
|
2017
Q4 | $21M | Buy |
1,300,448
+718,448
| +123% | +$8.48M | 0.83% | 44 |
|
|
2017
Q3 | $8.14M | Buy |
+582,000
| New | +$5.8M | 0.37% | 67 |
|
|
2016
Q1 | – | Sell |
-1,073,640
| Closed | -$3.3M | – | 120 |
|
|
2015
Q4 | $3.3M | Buy |
+1,073,640
| New | +$3M | 0.13% | 92 |
|
|
2015
Q3 | – | Sell |
-2,505,872
| Closed | -$10.2M | – | 145 |
|
|
2015
Q2 | $10.2M | Sell |
2,505,872
-100
| -0% | -$409 | 0.34% | 70 |
|
|
2015
Q1 | $9.6M | Sell |
2,505,972
-300,000
| -11% | -$1.3M | 0.31% | 66 |
|
|
2014
Q4 | $13.5M | Hold |
2,805,972
| – | – | 0.48% | 52 |
|
|
2014
Q3 | $10.4M | Hold |
2,805,972
| – | – | 0.38% | 69 |
|
|
2014
Q2 | $10.2M | Buy |
2,805,972
+177,000
| +7% | +$650K | 0.41% | 65 |
|
|
2014
Q1 | $11.1M | Buy |
+2,628,972
| New | +$13M | 0.45% | 60 |
|
Deerfield Management's IMMU Position: Q4 2020 in Review
Deerfield Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 2,304,900 shares — an estimated $196M sold.
Deerfield Management first reported a position in IMMU in Q1 2014 and held it in 20 quarters. The position peaked at $196M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- Deerfield Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- Deerfield Management sold 2,304,900 Immunomedics Inc shares in Q4 2020, an estimated $196M.
- Deerfield Management first reported a position in Immunomedics Inc in Q1 2014 and held it in 20 quarters.
- Deerfield Management's Immunomedics Inc position peaked at $196M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on Deerfield Management's 13F filing for Q4 2020, filed 16 Feb 2021.